Prostate Cancer Reports


Volume 2 Number 1
 January 2014

Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Number 1, January 2014

CONTENTS

Diagnosis and evaluation
Etiology and pathogenesis
Integrative medicine
Nomograms
Oncological outcomes
Progression
Risk stratification
Statins
Survival
Treatment
Treatment comparison
Treatment decision making


DIAGNOSIS AND EVALUATION

Hernández-Sánchez JE, Castillo E, Barbero JM, Lista F, Gonzalez J.
Prediction of extracapsular disease with multiparametric magnetic resonance imaging in high risk localized prostate cancer patient.
Arch Esp Urol. 2013 Dec;66(10):956-66. English, Spanish.
Abstract | Related citations

ETIOLOGY AND PATHOGENESIS


Barnett CM, Heinrich MC, Lim J, Nelson D, Beadling C, Warrick A, Neff T, Higano CS, Garzotto M, Qian D, Corless CL, Thomas GV, Beer TM.
Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer.
Clin Cancer Res. 2014 Feb 6. [Epub ahead of print]
Abstract | Related citations


Moritz R, Ellinger J, Nuhn P, Haese A, Müller SC, Graefen M, Schlomm T, Bastian PJ.
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer.
Anticancer Res. 2013 Dec;33(12):5249-54.
Abstract | Related citations

INTEGRATIVE MEDICINE



Ax E, Garmo H, Grundmark B, Bill-Axelson A, Holmberg L, Becker W, Zethelius B, Cederholm T, Sjögren P.
Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men.
Nutr Cancer. 2014 Jan;66(1):77-87. doi: 10.1080/01635581.2014.851712. Epub 2013 Dec 10.
Abstract | Related citations


Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z.
Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies.
Carcinogenesis. 2014 Jan 13. [Epub ahead of print]
Abstract | Related citations



Cardwell CR, Flahavan EM, Hughes CM, Coleman HG, O'Sullivan JM, Powe DG, Murray LJ.
Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Cancer Causes Control. 2014 Jan;25(1):33-43. doi: 10.1007/s10552-013-0306-x. Epub 2013 Dec 6.
Abstract | Related citations



Fontana L, Adelaiye RM, Rastelli AL, Miles KM, Ciamporcero E, Longo VD, Nguyen H, Vessella R, Pili R.
Dietary protein restriction inhibits tumor growth in human xenograft models.
Oncotarget. 2013 Dec;4(12):2451-61.
Abstract | Full textRelated citations



Flahavan EM, Bennett K, Sharp L, Barron TI.
A cohort study investigating aspirin use and survival in men with prostate cancer.
Ann Oncol. 2014 Jan;25(1):154-9. doi: 10.1093/annonc/mdt428.
Abstract | Related citations


Taneja SS.
Re: effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
J Urol. 2014 Jan;191(1):74-6. doi: 10.1016/j.juro.2013.09.076. Epub 2013 Oct 4.
Abstract | Full text | Comment on | Related citations


Taneja SS.
Re: consumption of fish products across the lifespan and prostate cancer risk.
J Urol. 2014 Jan;191(1):74-5. doi: 10.1016/j.juro.2013.09.079. Epub 2013 Oct 5.
Abstract | Full text | Comment on | Related citations


Zhong S, Chen W, Yu X, Chen Z, Hu Q, Zhao J.
Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis.
Eur J Clin Nutr. 2013 Dec 4. doi: 10.1038/ejcn.2013.256. [Epub ahead of print]
Abstract | Related citations

NOMOGRAMS



Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.
Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy.
Eur Urol. 2014 Sep 1. pii: S0302-2838(13)01309-2. doi: 10.1016/j.eururo.2013.11.045. [Epub 2013 Dec 12]
Abstract | Full text | Related citations


Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Redorta JP, Graefen M, Guazzoni G.
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy.
Eur Urol. 2013 Dec 16. pii: S0302-2838(13)01326-2. doi: 10.1016/j.eururo.2013.12.005. [Epub ahead of print]
Abstract | Related citations


Mearini L, Gacci M, Saleh O, De Nunzio C, Schiavina R, Simonato A, Tubaro A, Carmignani G, Mirone V, Carini M, Bini V, Porena M.
External Validation of Nomogram Predicting the Probability of Specimen-Confined Disease (pT2-3a, R0N0) in Patients Undergoing Radical Prostatectomy and Pelvic Lymph Node Dissection.
Urol Int. 2013 Dec 14. [Epub ahead of print]
Abstract | Related citations

ONCOLOGIC OUTCOMES



Lin S, Zhang Q, Li P, Li Z, Sun Y, Shao Y, Zhang X, Fu S.
Prediction of Extraprostatic Extension in Patients with Clinically Organ-Confined Prostate Cancer.
Urol Int. 2013 Nov 20. [Epub ahead of print]
Abstract | Related citations

PROGRESSION

Zhao H, Logothetis CJ, Gorlov IP, Zeng J, Dai J.
Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.
Comput Math Methods Med. 2013;2013:917502. doi: 10.1155/2013/917502. Epub 2013 Dec 4.
Abstract | Full text | Related citations

RISK STRATIFICATION



Mandel P, Kretschmer A, Chandrasekar T, Nguyen HG, Buchner A, Stief CG, Tilki D.
The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy.
Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00348-7. doi: 10.1016/j.urolonc.2013.09.005. [Epub ahead of print]
Abstract | Related citations

STATINS



Moon H, Hill MM, Roberts MJ, Gardiner RA, Brown AJ.
Statins: protectors or pretenders in prostate cancer?
Trends Endocrinol Metab. 2014 Jan 22. pii: S1043-2760(13)00215-4. doi: 10.1016/j.tem.2013.12.007. [Epub ahead of print]
Abstract | Full text | Related citations

SURVIVAL




De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study.
Lancet Oncol. 2014 Jan;15(1):23-34. doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5.
Abstract | Related citations


Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.
Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.
Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00405-5. doi: 10.1016/j.urolonc.2013.10.001. [Epub ahead of print]
Abstract | Related citations


Froehner M, Koch R, Wirth MP, Adam M, Schlomm T, Huland H, Graefen M.
Does increasing life expectancy affect competing mortality after radical prostatectomy?
Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00446-8. doi: 10.1016/j.urolonc.2013.10.006. [Epub ahead of print]
Abstract | Related citations

TREATMENT



Overviews

Loeb S.
The age old question: who benefits from prostate cancer treatment?
BJU Int. 2014 Jan;113(1):4. doi: 10.1111/bju.12184.
Abstract | Full text | Related citations


Keyes M, Crook J, Morton G, Vigneault E, Usmani N, Morris WJ.
Treatment options for localized prostate cancer.
Can Fam Physician. 2013 Dec;59(12):1269-74.
Abstract | Full text | Related citations


First treatment

Pal SK, Ruel N, Vogelzang N, Chang M, Wilson TG, Jones JO, Yuh B.
Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease.
Clin Genitourin Cancer. 2013 Nov 12. pii: S1558-7673(13)00280-2. doi: 10.1016/j.clgc.2013.11.009. [Epub ahead of print]
Abstract | Related citations


Second-line-treatment

Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Trinh QD, Lynch JH, Collins SP, Hu JC.
Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.
Urol Oncol. 2013 Dec 6. pii: S1078-1439(13)00347-5. doi: 10.1016/j.urolonc.2013.09.004. [Epub ahead of print]
Abstract | Related citations


Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, Breau RH
Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.
PLoS One. 2013 Nov 4;8(11):e79773. doi: 10.1371/journal.pone.0079773. eCollection 2013.
Abstract | Full text | Related citations


Shelan M, Abo-Madyan Y, Welzel G, Bolenz C, Kosakowski J, Behnam N, Wenz F, Lohr F.
Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity.
Radiat Oncol. 2013 Nov 27;8:276. doi: 10.1186/1748-717X-8-276.
Abstract | Full text | Related citations

TREATMENT COMPARISON




Clyne M.
Prostate cancer: Open vs laparoscopic vs robotic RP-the biggest study to date.
Nat Rev Urol. 2014 Jan;11(1):6. doi: 10.1038/nrurol.2013.306. Epub 2013 Dec 10.
Abstract | Related citations



Sandoval Salinas C, González Rangel AL, Cataño Cataño JG, Fuentes Pachón JC, Castillo Londoño JS.
Efficacy of Robotic-Assisted Prostatectomy in Localized Prostate Cancer: A Systematic Review of Clinical Trials.
Adv Urol. 2013;2013:105651. Epub 2013 Nov 10.
Abstract | Full text | Related citations



Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG, Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM, Steyerberg E, Roobol MJ, Tewari AK.
A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients.
Eur Urol. 2013 Nov 24. pii: S0302-2838(13)01215-3. doi: 10.1016/j.eururo.2013.11.018. [Epub ahead of print]
Abstract | Full text | Related citations

TREATMENT DECISION MAKING


Jereczek-Fossa BA, Rodari M, Bonora M, Fanti P, Fodor C, Pepe G, Lopci E, Zerini D, Vischioni B, Baroni G, Matei DV, De Cobelli O, Chiti A, Orecchia R.
[11C]Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy.
Clin Genitourin Cancer. 2013 Nov 12. pii: S1558-7673(13)00271-1. doi: 10.1016/j.clgc.2013.11.002. [Epub ahead of print]
Abstract | Related citations